The new machine is fully automated and capable of filling and over-encapsulating a wide range of solid and liquid products.
At present it has filling stations for powders, granules, pellets, tablets, capsules and micro tablets.
The machine also has the additional security of having 100% online weight control of each capsule.
NextPharma’s Gottingen CTS facility has extensive capacity in packaging suites for primary and secondary packaging and an extended cold storage area (2-8 °C and – 20 °C).
It has a dedicated packaging suite for secondary packaging of high potency drugs, such as cytotoxics and the capability to perform primary packaging under inert gas conditions.
Besides providing packaging and distribution services for non clinical, Phase I and Phase II clinical trials, the facility can also offer packaging and distribution capacity for large Phase III and IV trials.
NextPharma also has CTS capabilities at its FDA inspected San Diego, California, US facility which mirror its Gottingen CTS facility.